One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.
Blood Cancer J
; 13(1): 8, 2023 01 05.
Article
de En
| MEDLINE
| ID: mdl-36599843
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
COVID-19
Type d'étude:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limites:
Female
/
Humans
Langue:
En
Journal:
Blood Cancer J
Année:
2023
Type de document:
Article
Pays d'affiliation:
Espagne
Pays de publication:
États-Unis d'Amérique